Viewing Study NCT06640166


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-25 @ 2:31 PM
Study NCT ID: NCT06640166
Status: RECRUITING
Last Update Posted: 2025-02-12
First Post: 2024-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module